Regeneron Pharmaceuticals (REGN) Stock Price, Quote & News

Company Profile

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascul...

Industry: Biotechnology

Sector: Healthcare

Phone: 914 847 7000

Website: www.regeneron.com

Address:

777 Old Saw Mill River Road, Tarrytown, United States

DidYouReadThis Aug. 18 at 7:55 PM

I like both $REGN AND $OTLK ! Dear Team $REGN, care to shoutout some ideas about eyes and wet AMD? What potential reasons am I forgetting about?

0 · Reply

Whiskeyunderthebed Aug. 18 at 4:19 PM

$REGN Take out the 52 week HIGH @ 821- you can do it!

0 · Reply

OffHisGame88 Aug. 18 at 4:08 PM

$REGN another strong defensive for September October

0 · Reply

DidYouReadThis Aug. 17 at 7:01 PM

$OTLK Do you see $OTLK maybe going under 50 cents a share by the end of the year despite a July FDA approval? $REGN $ABBV $IBB

1 · Reply

Tom2772 Aug. 17 at 1:36 PM

$OTLK $REGN $TSLA Sounds really good!

0 · Reply

Whiskeyunderthebed Aug. 17 at 12:51 PM

$REGN maybe we can get a push from this today.

0 · Reply

stevemano Aug. 16 at 5:42 PM

$REGN I can remember when REGN was at four dollars after the Sanofi divorce. All the trolls were out in force saying it was the end of the world and they’re gonna only hold it for a short while or they’re gonna sell right away. What’s the percent return from $4.50 to $1200?? forget the trolls!

0 · Reply

HedgeFollow Aug. 14 at 4:09 PM

🔍 𝗔𝗹𝗽𝗶𝗻𝗲 𝗙𝗼𝘅 13𝗙 is 𝗢𝗨𝗧🔎 Rising-star Fund Manager Mike Alfred just filed his 13F. 𝘔𝘰𝘴𝘵 𝘯𝘰𝘵𝘢𝘣𝘭𝘦 𝘱𝘰𝘴𝘪𝘵𝘪𝘰𝘯 𝘤𝘩𝘢𝘯𝘨𝘦𝘴 𝘪𝘯 𝘘2: 𝗡𝗲𝘄 𝗕𝘂𝘆𝘀: $SLNH 𝗔𝗱𝗱𝗲𝗱 20-30% 𝗺𝗼𝗿𝗲: $NVO 𝗗𝗢𝗨𝗕𝗟𝗘𝗗 position: $OPEN Heavily 𝗕𝗢𝗢𝗦𝗧𝗘𝗗: $BKKT 𝗥𝗲𝗱𝘂𝗰𝗲𝗱 by 50%: $REGN Mike's 𝗽𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗶𝘀 𝗨𝗣 48.94% in Q2 alone. Keep an eye on good Hedge Fund managers like him. Source: hedgefollow.com/funds/Alpine+Fox+Capital+LLC

3 · Reply

Top_Dog_Pro_Trader Aug. 14 at 1:30 PM

$SGMO sounds like $LLY back room deal with Sandy might not stand a legal challenge IMO! $REGN $$RHHBY . These assets should have been part of the auction! What a scam/steal by $LLY to try and do this, don’t they have any morals? The sales prices are a tr garage sale prices for assets that can move the needle for even $LLY! One way someone can get around the lawsuit is to buy out the rest of the pipeline. You get the pipeline for some of the future milestone payments, which look very achievable! Come on guys, do you go to church, do you have any ethics? Just offer a decent price!

0 · Reply

genesee273 Aug. 14 at 1:05 PM

$OTLK BUYOUT from $RHHBY or $REGN would be Wonderful

0 · Reply

Regeneron price target raised to $824 from $641 at Leerink

2026-08-06T15:35:28.000Z - 12 days ago

Regeneron announces Health Canada approval of new indication for Libtayo

2026-08-03T13:30:28.000Z - 16 days ago

Regeneron price target raised to $1,030 from $1,000 at Guggenheim

Aug 3, 2026, 7:05 AM EDT - 16 days ago

Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron's Eylea® 2 mg

2026-08-03T10:41:45.000Z - 16 days ago

Regeneron price target raised to $740 from $700 at Citi

2026-07-31T14:05:59.000Z - 18 days ago

Regeneron price target raised to $737 from $696 at RBC Capital

SNY

2026-07-31T13:11:01.000Z - 19 days ago

Regeneron price target raised to $758 from $730 at Morgan Stanley

2026-07-31T13:01:58.000Z - 19 days ago

Regeneron price target raised to $891 from $856 at BofA

2026-07-31T12:37:44.000Z - 19 days ago

Regeneron price target raised to $795 from $750 at Cantor Fitzgerald

2026-07-31T11:25:46.000Z - 19 days ago

Regeneron price target raised to $761 from $742 at Baird

Jul 31, 2026, 7:00 AM EDT - 19 days ago

Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

2026-07-31T10:20:46.000Z - 19 days ago

Regeneron price target raised to $750 from $700 at Wells Fargo

Jul 30, 2026, 8:30 AM EDT - 20 days ago

Regeneron Pharmaceuticals Earnings Call Transcript: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 20 days ago

Regeneron Pharmaceuticals Earnings release: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 20 days ago

Regeneron Pharmaceuticals Quarterly report: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 20 days ago

Regeneron Pharmaceuticals Slides: Q2 2026

2026-07-30T12:21:28.000Z - 20 days ago

Regeneron cuts FY26 CapEx view to $1.03B-$1.1B from $1.1B-$1.2B

Jul 30, 2026, 7:54 AM EDT - 20 days ago

Regeneron beats quarterly estimates on eczema drug strength, shares rise

2026-07-30T10:35:57.000Z - 20 days ago

Regeneron reports Q2 adjusted EPS $14.29, consensus $10.20

Jul 30, 2026, 6:30 AM EDT - 20 days ago

Regeneron Reports Second Quarter 2026 Financial and Operating Results

Jul 29, 2026, 10:27 PM EDT - 20 days ago

REGN Stockholders Have Rights – If You Lost Money Investing in Regeneron Pharmaceuticals, Inc. Contact Robbins LLP for Information About Recovering Your Losses

Jul 24, 2026, 1:40 PM EDT - 25 days ago

The Scientist With 1,000 Patents Fueling a Drug Powerhouse

Jul 24, 2026, 6:36 AM EDT - 26 days ago

$REGN Fraud Notification: Regeneron Sued for Fraud Over Misrepresentations about its Clinical Trials – Investors Notified to Contact BFA Law

Jul 23, 2026, 10:09 AM EDT - 26 days ago

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regeneron Pharmaceuticals, Inc. Lawsuit - REGN

Jul 21, 2026, 4:03 PM EDT - 4 weeks ago

REGN Breaking News: Regeneron Inc. Sued for Securities Fraud after Revealing Failed Phase III Clinical Trial Resulting in 10% Stock Drop – Investors Notified to Contact BFA Law

2026-07-21T12:06:20.000Z - 4 weeks ago

Regeneron price target raised to $1,000 from $995 at Guggenheim

Jul 20, 2026, 2:42 PM EDT - 4 weeks ago

REGENERNON PHARMACEUTICALS, INC. (REGN) INVESTOR ALERT Investors With Large Losses in Regeneron Pharmaceuticals, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

2026-07-20T11:35:36.000Z - 4 weeks ago

Biohaven enters into clinical supply agreement with Regeneron

BHVN

Jul 15, 2026, 1:20 PM EDT - 4 weeks ago

Booking, Alphabet, and 7 Other Stocks to Buy Ahead of Earnings

BKNG GOOG GOOGL PAYC PAYX SYK EVR

2026-07-14T21:05:12.000Z - 5 weeks ago

Regeneron’s dupilumab granted orphan drug designation

2026-07-13T11:21:03.000Z - 5 weeks ago

Regeneron price target lowered to $856 from $860 at BofA

2026-07-09T11:15:17.000Z - 5 weeks ago

Regeneron price target lowered to $854 from $855 at Piper Sandler

2026-07-08T11:40:11.000Z - 6 weeks ago

Regeneron price target lowered to $730 from $788 at Morgan Stanley

Jun 29, 2026, 3:03 PM EDT - 7 weeks ago

FDA selects Lilly, Regeneron for program to speed up review of new manufacturing facilities, CNBC reports

LLY

Jun 29, 2026, 2:50 PM EDT - 7 weeks ago

Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities

LLY

Jun 25, 2026, 4:05 PM EDT - 7 weeks ago

Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast

Jun 22, 2026, 7:00 AM EDT - 2 months ago

Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)

Jun 12, 2026, 10:30 AM EDT - 2 months ago

Regeneron Pharmaceuticals Transcript: AGM 2026

Jun 12, 2026, 10:30 AM EDT - 2 months ago

Regeneron Pharmaceuticals Slides: FY 2026

Jun 8, 2026, 2:00 PM EDT - 2 months ago

Regeneron Pharmaceuticals Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 4, 2026, 7:00 AM EDT - 2 months ago

Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO

May 28, 2026, 4:00 PM EDT - 2 months ago

Regeneron's Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak

May 25, 2026, 11:31 AM EDT - 3 months ago

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Regeneron Pharmaceuticals, Inc. (REGN)

May 22, 2026, 7:00 AM EDT - 3 months ago

Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss

May 21, 2026, 5:01 PM EDT - 3 months ago

Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis

May 18, 2026, 3:25 PM EDT - 3 months ago

Regeneron stock drops double digits on oncology trial failure

May 18, 2026, 7:28 AM EDT - 3 months ago

Regeneron Stock Sinks as Key Melanoma Drug Trial Fails to Beat Merck's Keytruda

May 18, 2026, 7:04 AM EDT - 3 months ago

Regeneron Shares Slide Premarket after Melanoma Drug Trial Disappoints

May 18, 2026, 7:00 AM EDT - 3 months ago

Regeneron Announces Strategic Collaboration with Parabilis Medicines to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas

May 18, 2026, 7:00 AM EDT - 3 months ago

Parabilis Medicines Announces Strategic Collaboration with Regeneron Pharmaceuticals to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas

May 18, 2026, 5:57 AM EDT - 3 months ago

Regeneron drops after skin cancer treatment misses late-stage trial goal

May 15, 2026, 8:19 PM EDT - 3 months ago

Regeneron Provides Update on Phase 3 Trial of Fianlimab (LAG-3 Inhibitor) Combination in First-Line Unresectable or Metastatic Melanoma

May 15, 2026, 5:56 PM EDT - 3 months ago

UPDATE – Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair

May 15, 2026, 4:27 PM EDT - 3 months ago

Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair

May 12, 2026, 1:00 PM EDT - 3 months ago

Regeneron Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026

May 8, 2026, 7:00 AM EDT - 3 months ago

Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years

May 5, 2026, 7:00 AM EDT - 3 months ago

Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial

Apr 29, 2026, 8:30 AM EDT - 4 months ago

Regeneron Pharmaceuticals Earnings Call Transcript: Q1 2026

Apr 29, 2026, 8:30 AM EDT - 4 months ago

Regeneron Pharmaceuticals Earnings release: Q1 2026

Apr 29, 2026, 8:30 AM EDT - 4 months ago

Regeneron Pharmaceuticals Quarterly report: Q1 2026

Apr 29, 2026, 8:30 AM EDT - 4 months ago

Regeneron Pharmaceuticals Slides: Q1 2026

Apr 29, 2026, 7:43 AM EDT - 4 months ago

Regeneron beats quarterly results estimates on strong Dupixent demand

Apr 29, 2026, 6:30 AM EDT - 4 months ago

Regeneron Reports First Quarter 2026 Financial and Operating Results

Apr 24, 2026, 2:37 PM EDT - 4 months ago

Regeneron weighs overseas price for Otarmeni, gene therapy for rare type of hearing loss

Apr 24, 2026, 10:30 AM EDT - 4 months ago

Regeneron CEO on deal with Trump admin to lower drug prices

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Regeneron Pharmaceuticals Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Regeneron Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 3:46 PM EDT - 4 months ago

Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.

DidYouReadThis Aug. 18 at 7:55 PM

I like both $REGN AND $OTLK ! Dear Team $REGN, care to shoutout some ideas about eyes and wet AMD? What potential reasons am I forgetting about?

0 · Reply

Whiskeyunderthebed Aug. 18 at 4:19 PM

$REGN Take out the 52 week HIGH @ 821- you can do it!

0 · Reply

OffHisGame88 Aug. 18 at 4:08 PM

$REGN another strong defensive for September October

0 · Reply

DidYouReadThis Aug. 17 at 7:01 PM

$OTLK Do you see $OTLK maybe going under 50 cents a share by the end of the year despite a July FDA approval? $REGN $ABBV $IBB

1 · Reply

Tom2772 Aug. 17 at 1:36 PM

$OTLK $REGN $TSLA Sounds really good!

0 · Reply

Whiskeyunderthebed Aug. 17 at 12:51 PM

$REGN maybe we can get a push from this today.

0 · Reply

stevemano Aug. 16 at 5:42 PM

0 · Reply

HedgeFollow Aug. 14 at 4:09 PM

3 · Reply

Top_Dog_Pro_Trader Aug. 14 at 1:30 PM

0 · Reply

genesee273 Aug. 14 at 1:05 PM

$OTLK BUYOUT from $RHHBY or $REGN would be Wonderful

0 · Reply

DidYouReadThis Aug. 14 at 12:49 PM

$REGN $OTLK $NVS $BAYRY What does FDA approved bevacizumab cost for wet AMD?

1 · Reply

DidYouReadThis Aug. 14 at 12:00 PM

$REGN $NVS $ABBV $JNJ Are you more:

0 · Reply

DidYouReadThis Aug. 13 at 7:05 PM

$OTLK #Big #Congrats on #FDAApproval for bevacizumab for wet AMD! “History doesn’t repeat itself but it often rhymes” Mark Twain How many years ago did #foxbusiness have this article? https://www.foxbusiness.com/markets/better-buy-regeneron-pharmaceuticals-inc-vs-novartis.amp $NVS $REGN $BRK.B How many companies with an FDA approval for wet age related macular degeneration have a market cap below 10 billion dollars?

0 · Reply

focafoca99 Aug. 13 at 6:30 PM

$REGN receives a securities class-action alert from SueWallSt alleging misstatements in its Phase III trial.

0 · Reply

Whiskeyunderthebed Aug. 13 at 4:29 PM

$REGN nice buys today... keep chuggin

0 · Reply

DidYouReadThis Aug. 12 at 9:02 PM

Here we go again? #trending #yet? $OTLK $ABBV $REGN $JNJ

0 · Reply

SilverEagle Aug. 12 at 11:54 AM

$REGN 10 ema crossed back over the 20. Watching over 825 for a push back to 1K

1 · Reply

DidYouReadThis Aug. 10 at 8:10 PM

$OTLK $REGN $ABBV $NVS #Retina is a very exciting space to try helping people! #Congrats to #Outlook Therapeutics on receiving an FDA approval for bevacizumab for wet AMD! What are your guesses? Especially for the under 10-#bagger predictors, what’s your #target #maximum share price or #market cap over the next 12 years, and which year do you expect #peak #earnings? What do you think the maximum #PE ratio might be? How low are your #minimums for all? After 2 years of earnings between combined outside and inside the #USA, maybe a potential #minimum could be guessed: PE of 4 market cap of 240M share price of 1.33 peak earnings years 4-6, Q4s One maximum potential guess PE 44-74 market cap 35B 58.33-175 per share peak earnings year 5, Q4

0 · Reply

patorjk Aug. 10 at 8:00 PM

$REGN I picked some up in mid May but haven’t been paying attention the past few weeks. Is this mostly popping due to Q2 earnings? Where does everyone think it will go from here?

1 · Reply

Tom2772 Aug. 10 at 6:31 PM

$OTLK $SLS $REGN $REPL The rocket is just getting started 12 years of exclusivity FDA approved Commercialization ahead. Buckle up 💎

0 · Reply

Iwannagofast1 Aug. 10 at 5:14 PM

$REGN My baby making the sustained charge at last . I knew this would double for me eventually.

0 · Reply

Whiskeyunderthebed Aug. 10 at 4:18 PM

$REGN WOWZY-there we have it $800...

0 · Reply

Market Cap	82.97B
Revenue (ttm)	14.34B
Net Income (ttm)	4.50B
EPS (ttm)	N/A
PE Ratio	20.62
Forward PE	18.16
Profit Margin	31.41%
Debt to Equity Ratio	0.06

Volume	779,000
Avg Vol	895,948
Day's Range	N/A - N/A
Shares Out	102.96M
Stochastic %K	81%
Beta	0.21
Analysts	Strong Sell
Price Target	$844.96